重組蛋白

重組蛋白是解析生物相互作用的關(guān)鍵工具,廣泛應(yīng)用于各類研究實驗中。無論是商業(yè)化產(chǎn)品,還是為特定研究定制的蛋白,它們都在多種科學(xué)應(yīng)用中發(fā)揮著不可替代的作用。
若您需要優(yōu)質(zhì)重組蛋白——已驗證的生物活性、低內(nèi)毒素水平、高純度——來為您的研究提供可靠支持,這里正是您的理想之選。
歷經(jīng)18年積累,華美生物已構(gòu)建覆蓋原核與真核的五大蛋白質(zhì)表達系統(tǒng)。我們擁有包括桿狀病毒外膜蛋白(OMP)表達技術(shù)、膜蛋白表達技術(shù)等在內(nèi)的多項蛋白表達與純化專有技術(shù),致力于為您提供高質(zhì)量的重組蛋白解決方案。
產(chǎn)品特點
- 覆蓋廣泛:擁有超過16,000種重組蛋白,涵蓋人類、小鼠、大鼠、兔、豚鼠、雞、猴、豬等多種物種的基因與靶點,支持跨物種比較研究。
- 表達系統(tǒng)全面:提供五大表達系統(tǒng),包括大腸桿菌、酵母、桿狀病毒-昆蟲細胞、哺乳動物細胞以及特有的無細胞表達系統(tǒng)。該系統(tǒng)省去質(zhì)粒轉(zhuǎn)化、細胞培養(yǎng)、破碎離心等步驟,顯著提升蛋白制備效率。
- 多標簽選擇:支持His、GST、Flag、MBP等多種標簽,便于后續(xù)純化、檢測與功能研究。
- 多領(lǐng)域應(yīng)用:適用于抗原制備、細胞與分析、蛋白互作、藥物研發(fā)、酶活性檢測、ELISA標準品、體內(nèi)外研究、質(zhì)譜與結(jié)構(gòu)分析等廣泛場景。
- 無動物源成分:我們已建立全程無動物副產(chǎn)品接觸的重組蛋白生產(chǎn)線,確保產(chǎn)品的高純凈性與一致性,適用于對來源敏感的各類實驗。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì),或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的重組蛋白,請查看華美生物蛋白定制服務(wù)。
通過選擇目標名稱的首字母瀏覽產(chǎn)品。
| 產(chǎn)品名稱 | 貨號 | 規(guī)格 |
|---|---|---|
| Recombinant Corynebacterium glutamicum Glutamate-1-semialdehyde 2,1-aminomutase (hemL) | CSB-YP839965DWY CSB-EP839965DWY CSB-BP839965DWY CSB-MP839965DWY CSB-EP839965DWY-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Corynebacterium glutamicum Recombination protein RecR (recR) | CSB-YP839966DWY CSB-EP839966DWY CSB-BP839966DWY CSB-MP839966DWY CSB-EP839966DWY-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Corynebacterium glutamicum Chromosomal replication initiator protein DnaA (dnaA), partial | CSB-YP839967DWY CSB-EP839967DWY CSB-BP839967DWY CSB-MP839967DWY CSB-EP839967DWY-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus UPF0397 protein MW2604 (MW2604), partial | CSB-YP839968SUL1 CSB-EP839968SUL1 CSB-BP839968SUL1 CSB-MP839968SUL1 CSB-EP839968SUL1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Histidine biosynthesis bifunctional protein HisIE (hisI) | CSB-YP839969SUL CSB-EP839969SUL CSB-BP839969SUL CSB-MP839969SUL CSB-EP839969SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Probable malate:quinone oxidoreductase 2 (mqo2) | CSB-YP839970SUL CSB-EP839970SUL CSB-BP839970SUL CSB-MP839970SUL CSB-EP839970SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Aspartate 1-decarboxylase (panD) | CSB-YP839971SUL CSB-EP839971SUL CSB-BP839971SUL CSB-MP839971SUL CSB-EP839971SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Putative surface protein MW2416 (MW2416), partial | CSB-YP839972SUL CSB-EP839972SUL CSB-BP839972SUL CSB-MP839972SUL CSB-EP839972SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Probable nitrate transporter narT (narT), partial | CSB-YP839973SUL CSB-EP839973SUL CSB-BP839973SUL CSB-MP839973SUL CSB-EP839973SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Uncharacterized HTH-type transcriptional regulator MW2284 (MW2284) | CSB-YP839974SUL CSB-EP839974SUL CSB-BP839974SUL CSB-MP839974SUL CSB-EP839974SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Formimidoylglutamase (hutG) | CSB-YP839975SUL CSB-EP839975SUL CSB-BP839975SUL CSB-MP839975SUL CSB-EP839975SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Urease accessory protein UreF (ureF) | CSB-YP839976SUL CSB-EP839976SUL CSB-BP839976SUL CSB-MP839976SUL CSB-EP839976SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Molybdopterin molybdenumtransferase (moeA) | CSB-YP839977SUL CSB-EP839977SUL CSB-BP839977SUL CSB-MP839977SUL CSB-EP839977SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS), partial | CSB-YP839978SUL CSB-EP839978SUL CSB-BP839978SUL CSB-MP839978SUL CSB-EP839978SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Probable transglycosylase sceD (sceD) | CSB-YP839979SUL CSB-EP839979SUL CSB-BP839979SUL CSB-MP839979SUL CSB-EP839979SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Serine-protein kinase rsbW (rsbW) | CSB-YP839980SUL CSB-EP839980SUL CSB-BP839980SUL CSB-MP839980SUL CSB-EP839980SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Uncharacterized leukocidin-like protein 2 (MW1942) | CSB-YP839981SUL CSB-EP839981SUL CSB-BP839981SUL CSB-MP839981SUL CSB-EP839981SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Uncharacterized RNA methyltransferase MW1838 (MW1838) | CSB-YP839982SUL CSB-EP839982SUL CSB-BP839982SUL CSB-MP839982SUL CSB-EP839982SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Signal transduction protein TRAP (traP) | CSB-YP839983SUL CSB-EP839983SUL CSB-BP839983SUL CSB-MP839983SUL CSB-EP839983SUL-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Staphylococcus aureus Protein CrcB homolog 1 (crcB1), partial | CSB-YP839984SUL1 CSB-EP839984SUL1 CSB-BP839984SUL1 CSB-MP839984SUL1 CSB-EP839984SUL1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。
第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條:如何選擇合適的表達載體?
表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。
根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022






